working

Sign up to access

Get access to our full offering from over 100 providers

Get access to our full offering from over 100 providers


Get Started
Already a member? Log in here

More Content

More Content

ImmuPharma CEO confident on P140 partnership as strong pharma interest extends timeline into 2026

Companies: ImmuPharma plc

ImmuPharma's Tim McCarthy details Lupuzor licensing deal with Avion Pharmaceuticals

Companies: ImmuPharma plc

Hybridan Small Cap Feast: 24 November 2025

Companies: SAAS SNX IMM SAA FAB POLX KRPZ MWE DSW TRLS

ImmuPharma chairman talks widening of portfolio and changing profile of the business

Companies: ImmuPharma plc

Allenby Capital TMT Update - 24.11.25 - TIDE.L, ENET.L

Companies: Ethernity Networks Ltd.

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top